CRVS - Corvus Pharmaceuticals, Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
7.24 0.42 (5.8%)	---	---	-0.03 (-0.39%)	0.01 (0.14%)	0.57 (7.99%)	-0.06 (-0.78%)	-0.06 (-0.78%)

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.1
Diluted EPS:: -0.1
Basic P/E:: -76.6
Diluted P/E:: -76.6
RSI(14) 1m:: 0.0
VWAP:: 7.66
RVol:: 2.3405

Events

Period	Kind	Movement	Occurred At
Day	Rvol 2 increase day	rvol 2.0, 7.6 +0.35 (+4.9%)	Oct 15 15:07
1m	Price decrease 1m	7.52 -0.08 (-1.1%)	Oct 15 14:55
60m	Price increase 60m	7.21 +0.35 (+5.1%)	Oct 15 14:13
1m	Price increase 1m	7.16 +0.11 (+1.56%)	Oct 15 14:08
10m	Price increase 10m	7.16 +0.3 (+4.37%)	Oct 15 14:08